Home/Filings/4/0001140361-25-019899
4//SEC Filing

Shah Gaurav 4

Accession 0001140361-25-019899

CIK 0001281895other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:05 PM ET

Size

6.2 KB

Accession

0001140361-25-019899

Insider Transaction Report

Form 4
Period: 2025-05-16
Shah Gaurav
DirectorCEO
Transactions
  • Sale

    Common Stock

    2025-05-16$6.53/sh3,621$23,638789,059 total
Holdings
  • Common Stock

    (indirect: By Trust)
    198,341
  • Common Stock

    (indirect: By Spouse)
    207,897
Footnotes (2)
  • [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  • [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Issuer

ROCKET PHARMACEUTICALS, INC.

CIK 0001281895

Entity typeother

Related Parties

1
  • filerCIK 0001725922

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:05 PM ET
Size
6.2 KB